Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

BUY
$6.87 - $26.45 $351,057 - $1.35 Million
51,100 Added 327.56%
66,700 $598,000
Q4 2023

Feb 14, 2024

BUY
$11.28 - $25.46 $175,968 - $397,176
15,600 New
15,600 $387,000
Q3 2021

Nov 15, 2021

SELL
$29.86 - $39.47 $1.18 Million - $1.56 Million
-39,600 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$17.99 - $40.02 $712,403 - $1.58 Million
39,600 New
39,600 $1.26 Million

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $33.8M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.